Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Feaster

Showing results (221-230 of 249) with videos related to

Pageof 25
Sort By:
JAMA Psychiatry|October 4, 2023
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder TreatmentSean X Luo, Daniel J Feaster, Ying Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2020
"Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus EpidemicBohdan Nosyk, Emanuel Krebs, Xiao Zang, et al.
AIDS and Behavior|December 31, 2024
Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network StudySusan Tross, Tanja C Laschober, Margaret Paschen-Wolff, et al.
AIDS Care|July 30, 2025
Linear growth modeling of religious coping and social support among Black women living with HIV in the context of the COVID-19 pandemicRachelle A Reid, Michael Robinson, Reyanna St Juste, et al.
Trials|April 24, 2022
M<sup>2</sup>HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWIDValérie Martel-Laferrière, Daniel J Feaster, Lisa R Metsch, et al.
Trials|September 27, 2022
Correction: M<sup>2</sup>HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWIDValérie Martel-Laferrière, Daniel J Feaster, Lisa R Metsch, et al.
American Journal of Public Health|April 21, 2012
Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trialLisa R Metsch, Daniel J Feaster, Lauren Gooden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2021
Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US CitiesXiao Zang, Cassandra Mah, Amanda My Linh Quan, et al.
Addiction (Abingdon, England)|June 12, 2026
The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities StudyAlexander Y Walley, Debbie M Cheng, Nathan Vandergrift, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Pageof 25

Showing results (221-230 of 249) with videos related to

Sort By:
Pageof 25
JAMA Psychiatry|October 4, 2023
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder TreatmentSean X Luo, Daniel J Feaster, Ying Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2020
"Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus EpidemicBohdan Nosyk, Emanuel Krebs, Xiao Zang, et al.
AIDS and Behavior|December 31, 2024
Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network StudySusan Tross, Tanja C Laschober, Margaret Paschen-Wolff, et al.
AIDS Care|July 30, 2025
Linear growth modeling of religious coping and social support among Black women living with HIV in the context of the COVID-19 pandemicRachelle A Reid, Michael Robinson, Reyanna St Juste, et al.
Trials|April 24, 2022
M<sup>2</sup>HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWIDValérie Martel-Laferrière, Daniel J Feaster, Lisa R Metsch, et al.
Trials|September 27, 2022
Correction: M<sup>2</sup>HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWIDValérie Martel-Laferrière, Daniel J Feaster, Lisa R Metsch, et al.
American Journal of Public Health|April 21, 2012
Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trialLisa R Metsch, Daniel J Feaster, Lauren Gooden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2021
Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US CitiesXiao Zang, Cassandra Mah, Amanda My Linh Quan, et al.
Addiction (Abingdon, England)|June 12, 2026
The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities StudyAlexander Y Walley, Debbie M Cheng, Nathan Vandergrift, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Pageof 25